Screener
IDEAYA Biosciences, Inc. IDYA Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by IDEAYA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206357
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Accounts payable | $20,736 | $17,584 |
| Accrued liabilities | 43,745 | 40,892 |
| Operating lease liabilities, current | 350 | 339 |
| Total current liabilities | 64,831 | 58,815 |
| Long-term operating lease liabilities | 28,250 | 27,575 |
| Total liabilities | 93,081 | 86,390 |
| Commitments and contingencies (Note 6) | ||
| Stockholders’ equity |
Item 1. Financial Statements (UNAUDITED).
FAQ
- What is IDEAYA Biosciences, Inc.'s total current liabilities?
- IDEAYA Biosciences, Inc. (IDYA) reported total current liabilities of $64.83M in Q1 2026.
- How has IDEAYA Biosciences, Inc.'s total current liabilities changed year-over-year?
- IDEAYA Biosciences, Inc.'s total current liabilities increased by 27.5% year-over-year, from $50.85M to $64.83M.
- What is the long-term trend for IDEAYA Biosciences, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), IDEAYA Biosciences, Inc.'s total current liabilities has grown at a 8.8% compound annual growth rate (CAGR), from $38.64M to $58.82M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about IDEAYA Biosciences, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude